20916 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Sub-classes:MYOGENIC COMPOUNDS
#2COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS
#3METHODS AND COMPOSITIONS FOR RESTORING STMN2 LEVELS
#4METHODS FOR INCREASING TYPE I, III, AND V COLLAGEN IN AN ANIMAL
#5PHARMACEUTICAL FORMULATIONS
#6PHARMACEUTICAL FORMULATIONS
#7Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof
#8PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING PSP
#9METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) IN COMBINATION WITH GLP-1 AGONISTS
#10METHODS FOR TREATING HYPERINFLAMMATORY CONDITIONS USING LIPID BINDING PROTEIN -BASED COMPLEXES
#11ANTIMICROBIAL PEPTIDES
#12COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING METABOLIC DISORDERS
#13COMBINATION THERAPY COMPRISING GLP-2, AND INSULINOTROPIC PEPTIDE, TNFa INHIBITOR, OR BOTH FOR PREVENTING OR TREATING BOWEL DISEASE
#14DECELLULARIZED BIOMATERIAL FROM NON-MAMMALIAN TISSUE
#15PHARMACEUTICAL FORMULATIONS
#16TREATMENT SYSTEM FOR SYNERGISTICALLY INHIBITING A SPROUT ANGIOGENESIS
#17Compositions and Methods of Use for Recombinant Human Secretoglobins
#18PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION
#19STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION
#20ANTI-ANGIOGENIC TREATMENT USING ECHISTATIN WITH A BLOCKING PEPTIDE
#21REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF HEMORRHAGIC STROKE
#22SECRETOGLOBIN FAMILY 1D MEMBER 2 (SCGB1D2) PROTEIN INHIBITS GROWTH OF BORRELIA BURGDORFERI AND AFFECTS SUSCEPTIBILITY TO LYME DISEASE
#23EZRIN PEPTIDE 1 FOR USE IN A METHOD OF TREATING COVID-19
#24COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS
#25Methods and Compositions for Improving Quality of Life and Increasing Activity in Aging and Chronically Ill Mammals
#26Ocular Compositions and Methods Thereof
#27COMBINATION THERAPY FOR ALPORT RENAL DISEASE
#28METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGIC DISEASE
#29METHODS OF ISOLATING T CELLS AND T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION FROM PERIPHERAL BLOOD
#30Decellularized biomaterial from non-mammalian tissue
#31A DISINTEGRIN AND METALLOPROTEINASE WITH A THROMBOSPONDIN TYPE I MOTIF, MEMBER 13 (ADAMTS-13) MUTANTS, COMPOSITIONS AND THERAPEUTIC METHODS THEREOF
#32Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1)
#33Formulations and methods of use for alpha connexin c-terminal (ACT) peptides
#34COMPOSITIONS AND METHODS FOR TREATMENT
#35A NEW PROCESS OF PURIFICATION OF PROTEINS FROM HEN EGG WHITE AND THE USE OF THE SAME AS ANTIVIRAL AGENT AGAINST SARS-COV-2
#36PHARMACEUTICAL FORMULATIONS
#37Use of Cobra neurotoxin polypeptide molecule in the treatment of nephropathy proteinuria
#38NEW USE OF ANTIPLATELET THROMBOLYSIN
#39Methods of Assessing Unbound PCSK9 or Effective PCSK9 Activity
#40Compositions and methods for preventing or treating muscle conditions
#41FIBRIN BIOPOLYMER FORMATION AND APPLICATION DEVICE
#42Anti-angiogenic treatment using VLO4 with a blocking peptide
#43METHODS AND COMPOSITIONS FOR RESTORING STMN2 LEVELS
#44Antimicrobial peptides
#45ADHESIVE FOR OSSEOINTEGRATED PERCUTANEOUS DEVICES
#46Halogenated fullerene functionalized as a biocidal and chemotactic spermicide to vaginally harbor and neutralize spermatozoa for use as a safe and effective contraceptive
#47Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)
#48A METHOD FOR TREATING AN AUDITORY NEUROPATHY SPECTRUM DISORDER
#49PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION
#50ANTIMICROBIAL COATING COMPOSITIONS
#51Amino-reactive positively charged ATRP initiators that maintain their positive charge during synthesis of biomacro-initiators
#52Animal plasma or fractions thereof for use in treating cognitive impairment disorders in humans and companion animals
#53Combination therapies for inhibiting sprout angiogenesis in the treatment of cancers
#54REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF HEMORRHAGIC STROKE
#55Methods of inhibiting integrin α9β1 activity
#56Formulations and methods of use for alpha connexin c-terminal (ACT) peptides
#57Pharmaceutical Composition For Preventing Or Treating Tissue Adhesion Comprising Integrin a2ß1 Inhibitors
#58Methods and Compositions for Improving Quality of Life and Increasing Activity in Aging and Chronically Ill Mammals
#59METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#60Pharmaceutical or cosmetic composition for preventing or treating hair loss or promoting hair growth
#61Clotting composition
#62Compositions for inhibiting sprout angiogenesis
#63TUBULAR NANOSTRUCTURE TARGETED TO CELL MEMBRANE
#64Anti-angiogenic treatment with a combination of antagonists
#65USE OF CEREBROLYSIN
#66Stapled intracellular-targeting antimicrobial peptides to treat infection
#67Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#68METHODS AND COMPOSITIONS FOR MOBILIZING STEM CELLS
#69Compositions and methods of use for recombinant human secretoglobins
#70Methods and compositions for improving quality of life and increasing activity in aging and chronically ill mammals
#71PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION
#72Compositions and methods for treating diabetes, hypertension and hypercholesterolemia
#73Decellularized biomaterial from non-mammalian tissue
#74Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof
#75Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic acid
#76Use of upstream open reading frame 45aa-uORF nucleotide sequence of PTEN gene and polypeptide coded by 45aa-uORF
#77Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood
#78Use of selected single cobrotoxin molecule as an analgesic
#79Inhibiting sprout angiogenesis
#80Methods for alleviating, inhibiting or reversing muscle disuse atrophy in mammals
#81DEVICE FOR DELIVERY OF POWDERED HEMOSTATIC AGENTS
#82Topical formulations and methods
#83Pharmaceutical composition containing F1 polypeptide and/or F3 polypeptide and use thereof
#84Antimicrobial agents and compositions comprising the same
#85Rspondins as modulators of angiogenesis and vasculogenesis
#86Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
#87Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis
#88Nucleic Acid Complexes
#89Lebecetin, a C-type lectin, as neovascularization inhibitor
#90Therapeutic Compositions from the Brevinin-1 Family of Peptides and Uses Thereof
#91AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
#92Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
#93Decellularized Biomaterial from Non-Mammalian Tissue
#94Preventing central nervous system induced nausea through use of vitamin Bconjugation
#95ANTIMICROBIAL COATING COMPOSITIONS
#96METHOD FOR TREATING OR PREVENTING OSTEOARTHRITIS
#97RADIOLABELED DISINTEGRINS AS BRACHYTHERAPY AGENTS
#98Stimulation of ovarian follicle development and oocyte maturation
#99METHODS AND NON-IMMUNOGENIC COMPOSITIONS FOR TREATING INFLAMMATORY DISORDERS
#100Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic acid
#101Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood
#102Treatment of peripheral vascular disease using protein solutions
#103METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#104Nucleic acid complexes
#105METHOD OF TREATING MUCUS HYPERSECRETION
#106Clotting composition
#107Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
#108STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION
#109Pseudhymenochirins As Agents For Treatment Of Cancer And Microbial Infections
#110METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGIC DISEASE
#111Ocular Compositions and Methods Thereof
#112Methods and Compositions of P27KIP1 Transcriptional Modulators
#113Conditioned medium of liver progenitor cells
#114Tubular nanostructure targeted to cell membrane
#115AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
#116Uses of Humanized Cobra Venom Factor for Reducing or Preventing Immunogenicity
#117Targeting molecule and a use thereof
#118Genetically modified microorganisms
#119Genetically Modified Microorganisms
#120PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION
#121Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#122Method of diagnosis, prognostic or treatment of neurodegenerative disease
#123Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
#124MICROPARTICLES, BLOOD SUBSTITUTE AND METHOD FOR FORMING SAME
#125Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
#126Methods of treating cancers with peptide-based modulators
#127METHOD FOR TREATING OR PREVENTING NONALCOHOLIC FATTY LIVER DISEASE
#128Methods, systems, and compositions relating to miRNA-146a
#129Pan-antiviral peptides for protein kinase inhibition
#130Methods and compositions for mobilizing stem cells
#131-Prom mediated surface expression of avidin/streptavidin
#132Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
#133COMBINED PROTEIN SUPPLEMENTS
#134Methods and compositions of p27transcriptional modulators
#135FAM150A, FAM150B, AND FAM150 ANTAGONISTS AND USES THEREOF
#136Rspondins as modulators of angiogenesis and vasculogenesis
#137Use of PEDF-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis
#138Compositions and methods to inactivate and/or reduce production of microbial toxins
#139Decellularized biomaterial from non-mammalian tissue
#140Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
#141Peptide antagonists of the vasopressin-2 receptor
#142Method of obtaining effective amounts of avian follistatin
#143Nucleic acid complexes
#144Use of proteases for gluten intolerance
#145COMPOSITIONS AND METHODS FOR TREATMENT
#146COMPOSITIONS AND METHODS FOR TREATMENT
#147COMPOSITIONS AND METHODS FOR TREATMENT
#148COMPOSITIONS AND METHODS FOR TREATMENT
#149COMPOSITIONS AND METHODS FOR TREATMENT
#150COMPOSITIONS AND METHODS FOR TREATMENT
#151COMPOSITIONS AND METHODS FOR TREATMENT
#152ACETYLATED CRYSTALLIN POLYPEPTIDES AND MIMETICS THEREOF AS THERAPEUTIC AGENTS
#153Anti-angiogenic treatment of endothelial tissue with a combination of antagonists
#154Esculentin 1a derivatives and uses thereof
#155Genes and proteins associated with angiogenesis and uses thereof
#156Methods and composition for inducing satiety
#157GLYCOPROTEIN ENRICHED COMPOSITION AS A FOOD AND/OR FEED ADDITIVE AND/OR AS A THERAPEUTIC AGENT
#158Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
#159DERMASEPTIN B2 USED AS AN INHIBITOR OF THE GROWTH OF A TUMOR
#160Antagonist anti-Rspondin3 antibodies
#161Methods of use of HSP70 for increased performance or treatment of HSP70 related disorders
#162MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF CANCER
#163Stimulation of ovarian follicle development and oocyte maturation
#164Methods and non-immunogenic compositions for treating inflammatory disorders
#165Treatment of pain using protein solutions
#166Treatment of peripheral vascular disease using protein solutions
#167Treatment of inflammatory respiratory disease using biological solutions
#168AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
#169Compositions and methods for treatment
#170Method for treatment of diabetic vascular leakage-induced disease using C-peptide
#171Pharmaceutical composition of oxidised avidin suitable for inhalation
#172Method for prevention or treatment of diabetic angiogenesis impairment using C-peptide
#173Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy
#174METHODS FOR USING SEMAPHORIN POLYPEPTIDES
#175Rspondin antibodies as inhibiting factors of angiogenesis and vaculogenesis
#176Stable Pexiganan Formulation
#177Diagnostic and therapeutic uses of moesin fragments
#178Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same
#179Site-directed PEG-modified exendin-4 analogs and uses thereof
#180METHODS AND MEDICAMENTS FOR THE TREATMENT OF GOUT OR PSEUDOGOUT
#181Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
#182METHODS OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASES
#183Formulations having an antagonist of α5β1 for anti-angiogenesis and cancer treatment
#184Method of treating cancer with a composition containing a C12ORF59 protein
#185COMPOSITIONS AND METHODS FOR INHIBITING VIRAL INFECTION
#186Administration of an antagonist of α5β1 for anti-angiogenesis and cancer treatment
#187Sensitization of tumor cells to radiation therapy through administration of endothelin agonists
#188COMPOSITIONS AND METHODS FOR INCREASING POULTRY HATCHABILITY AND EARLY PERFORMANCE
#189ASSAYS AND METHODS USING BIOMARKERS
#190Methods for inhibiting hematopoiesis with a hedgehog antagonist
#191Nucleic acid complexes
#192COMPOSITIONS AND METHODS FOR TREATMENT OF PARKINSON'S DISEASE
#193Use of proteases for gluten intolerance
#194Inhibiting integrin receptor binding with non-native monomeric disintegrin or monomeric disintegrin domains
#195Genes and proteins associated with angiogenesis and uses thereof
#196Methods of treatment and screening assays for HIF-1α regulation
#197REGULATION OF EPITHELIAL TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO
#198Compositions and methods for treatment of eye disorders
#199Methods Relating to Peripheral Administration of Nogo Receptor Polypeptides
#200COMPOSITIONS AND METHODS FOR THERAPEUTIC MEMBRANE REPAIR
#201DERMASEPTIN B2 USED AS AN INHIBITOR OF THE GROWTH OF A TUMOR
#202Rspondin polypeptides as promoting factors of angiogenesis and vasculogenesis
#203Copolymer-1 improvements in compositions of copolymers
#204METHODS RELATING TO PERIPHERAL ADMINISTRATION OF NOGO RECEPTOR POLYPEPTIDES
#205Combination Therapy for Treatment of Cancer
#206COMBINED ADMINISTRATION OF INTEGRIN RECEPTOR ANTAGONISTS FOR ANTI-ANGIOGENIC THERAPY
#207Methods and compositions for contributing to the treatment of cancers
#208COMPOSITIONS FOR INCREASING HAIR GROWTH AND DECREASING HAIR LOSS
#209Methods and uses for inhibiting platelet coagulation
#210ANTI FUNGAL THERAPY
#211METHOD FOR THE TREATMENT OF GOUT OR PSEUDOGOUT
#212REGULATION OF MINERAL AND SKELETAL METABOLISM
#213TREATMENT OF DISEASES AND CONDITIONS MEDIATED BY INCREASED PHOSPHORYLATION
#214Treatment of diseases and conditions mediated by increased phosphorylation
#215Method of regulating proliferation and differentiation of keratinocyes
#216USE OF PROTEASES FOR GLUTEN INTOLERANCE
#217Pan-antiviral peptides for protein kinase inhibition
#218Tubular nanostructure targeted to cell membrane
#219Alpha-dystroglycan as a Protein Therapeutic
#220Compositions and methods for treatment
#221Compositions and methods for treatment
#222Composition for improving brain function and method for improving brain function
#223Compositions and methods for the treatment of angiogenesis-related eye diseases
#224Conditioned medium of liver progenitor cells
#225Cytomegalovirus disintegrin-like peptides
#226Methods of expressing proteins with disulfide bridges
#227Treatment of muscular dystrophies and related disorders
#228Pharmaceutical composition, use of the pharmaceutical composition for treating a brain tumor, production process thereof and a kit of parts comprising the pharmaceutical composition
#229DENDROASPIS NATRIURETIC PEPTIDE FOR TREATMENT OF CANCER
#230Compositions and methods for treating and preventing heart tissue degeneration and uses thereof
#231METHOD OF PREVENTING OR TREATING BODY WEIGHT DISORDERS BY EMPLOYING CLUSTERIN
#232Tubular nanostructure targeted to cell membrane
#233Methods of treatment of androgenic steroidal hormone dependent cancer with auger electron-emitting nucleoside analogs
#234ANTIMICROBIAL COMPOSITIONS AND USES THEREOF
#235Agent for the Treatment of Hormone-Dependent Disorders and Uses Thereof
#236Micro-particles, blood-substitute and method for forming same
#237PEPTIDES DERIVED FROM RAS-P21 AND USES THEREFOR
#238Trefoil Factors and Methods of Treating Proliferation Disorders Using Same
#239Regulation of TLR Signaling by Complement
#240Compositions and methods for treatment of eye disorders
#241COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS
#242Methods for inhibition of angiogenesis and vasculogenesis via rspondin antagonists
#243Tubular nanostructure targeted to cell membrane
#244Tubular nanostructure targeted to cell membrane
#245Methods of Use of Eggshell Polypeptides
#246Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
#247Coronin 1 modulators for the treatment of autoimmune and Lymphoproliferative disorders and mycobacterial infections
#248Lipocalin 2 for the Treatment, Prevention, and Management of Cancer Metastasis, Angiogenesis, and Fibrosis
#249METHODS FOR TREATING INFLAMMATION
#250Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation
#251Alpha-neurotoxin proteins with anti-inflammatory properties and uses thereof
#252Compositions and methods for altering Wnt autocrine signaling
#253Protection of Photoreceptors in Experimental Autoimmune Uveitis
#254Anti-microbial compositions comprising a cationic peptide and a glycylglycine endopeptidase
#255Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
#256MNTF differentiation and growth of stem cells
#257Compounds that Prevent Macrophage Apoptosis and Uses Thereof
#258Protein binding miniature proteins and uses thereof
#259TREATMENT OF HYPERSENSITIVITY
#260TREATMENT FOR MUCOSITIS
#261REGULATION OF MINERAL AND SKELETAL METABOLISM
#262REGULATION OF MINERAL AND SKELETAL METABOLISM
#263REGULATION OF MINERAL AND SKELETAL METABOLISM
#264Trefoil Factors and Methods of Treating Proliferation Disorders Using Same
#265METHOD FOR THE TREATMENT OF GOUT OR PSEUDOGOUT
#266REGULATION OF MINERAL AND SKELETAL METABOLISM
#267Assays and methods using biomarkers
#268Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists
#269Methods and compositions for contributing to the treatment of cancers
#270Novel morphogenic protein compositions of matter
#271Rage-related methods for treating and preventing diabetic retinopathy
#272Assays and methods using biomarkers
#273Antimicrobial Compositions and Uses Thereof
#274Modified elapid venoms as stimulators of the immune reaction
#275Process for controlling protein to salt ratio in animal muscle protein composition and protein composition
#276Combination Therapies Of Hmgb And Complement Inhibitors Against Inflammation
#277Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof
#278Combination therapy for treatment of cancer
#279Methods for the treatment of thrombosis
#280Compositions and methods for treating cancer
#281Grp Receptor-Related Methods for the Treating and Preventing Fear-Related Disorders
#282Dendroaspis natriuretic peptide for treatment of cancer
#283Galectin-glycosaminoglycan complex and method for controlling galectin activity
#284Suppressing polyglutamine aggregation and toxicity
#285Genes and proteins associated with angiogenesis and uses thereof
#286Methods of Using Gelsolin to Treat or Prevent Bacterial Sepsis
#287Two synthetic peptides for treatment and prevention of cancers
#288Use of cobratoxin as an analgesic
#289Morphogen compositions and methods of use thereof to treat heart disorders
#290Methods of preventing or treating brain ischemia or brain injury
#291METHOD FOR THE TREATMENT OF GOUT OR PSEUDOGOUT
#292Use of crotoxin as an analgesic - CIP
#293Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions
#294Copolymer-1 improvements in compositions of copolymers
#295Method of treating brain tissue damages
#296Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
#297REGULATION OF MINERAL AND SKELETAL METABOLISM
#298Compositions and methods of use of Semaphorin 3F and antagonists thereof in the stimulation of neuromuscular regeneration and treatment of muscular diseases
#299Syndecan 1 ectodomain inhibits cancer
#300Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof